Document is current
Any future updates will be listed below
-
Authors
Lee, V Vien https://orcid.org/0000-0002-0216-9032
Vijayakumar, Smrithi
Ng, Wei Ying https://orcid.org/0000-0003-4781-6413
Lau, Ni Yin
Leong, Qiao Ying
Ooi, Delicia Shu Qin https://orcid.org/0000-0001-8677-0126
Su, Lin Lin
Lee, Yung Seng https://orcid.org/0000-0002-1253-0557
Chan, Shiao-Yng https://orcid.org/0000-0002-3530-3023
Blasiak, Agata https://orcid.org/0000-0003-0727-7611
- License Information
-
More Information
Article History
Received: 10 February 2023
Accepted: 20 September 2023
First Online: 30 September 2023
Competing interests
: AB and DH are co-inventors or previously filed pending patents on artificial intelligence-based therapy development. DH is a shareholder of KYAN Therapeutics, which has licensed intellectual property pertaining to AI-based drug development. All other authors declare no financial or non-financial competing interests.
